Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia - Background and results

被引：3
|
作者：
Brune M. [1 ]
Romero A.I. [1 ]
Hellstrand K. [1 ]
机构：
[1] Department of Infectious Diseases, Sahlgrenska Academy, Göteborg University, Göteborg 413 46
来源：
Inflammation Research | 2009年 / 58卷 / Suppl 1期
关键词：
Natural Killer Cell; Acute Myeloid Leukemia; Acute Myeloid Leukemia Patient; Pediatric Acute Myeloid Leukemia; Acute Myeloid Leukemia Blast;
D O I：
10.1007/s00011-009-0642-1
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S4 / S8
页数：4
相关论文
共 50 条
  • [1] Histamine dihydrochloride and interleukin-2 in the treatment of acute myeloid leukemia
    Stadtmauer, EA
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 47 - 51
  • [2] Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia
    Thoren, Fredrik B.
    Romero, Ana I.
    Brune, Mats
    Hellstrand, Kristoffer
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (09) : 1217 - 1223
  • [3] Relapse Prevention in Acute Myeloid Leukemia: The Role of Immunotherapy with Histamine Dihydrochloride and Low-Dose Interleukin-2
    Montesinos, Pau
    Buccisano, Francesco
    Cluzeau, Thomas
    Vennstroem, Lovisa
    Heuser, Michael
    [J]. CANCERS, 2024, 16 (10)
  • [4] Age-Related Efficacy of Immunotherapy with Histamine Dihydrochloride and Interleukin-2 for Relapse Prevention in Acute Myeloid Leukemia
    Hellstrand, K.
    Thoren, F. B.
    Martner, A.
    Soderholm, J.
    Hofmann, W. K.
    Rowe, J. M.
    Brune, M.
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 : S30 - S32
  • [5] Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia
    Hallner, Alexander
    Aurelius, Johan
    Thoren, Fredrik Bergh
    Sander, Frida Ewald
    Brune, Mats
    Hellstrand, Kristoffer
    Martner, Anna
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 279 - 280
  • [6] Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
    Brune, Mats
    Castaigne, Sylvie
    Catalano, John
    Gehlsen, Kurt
    Ho, Anthony D.
    Hofmann, Wolf-Karsten
    Hogge, Donna E.
    Nilsson, Bo
    Or, Reuven
    Romero, Ana I.
    Rowe, Jacob M.
    Simonsson, Bengt
    Spearing, Ruth
    Stadtmauer, Edward A.
    Szer, Jeff
    Wallhult, Elisabeth
    Hellstrand, Kristoffer
    [J]. BLOOD, 2006, 108 (01) : 88 - 96
  • [7] Impact on quality of life of postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myelogenous leukemia
    Wallhult, Elisabeth
    Whisnant, John
    Rowe, Jacob M.
    Szer, Jeff
    Bhagwat, Dileep
    Hellstrand, Kristoffer
    Nilsson, Bo I.
    Brune, Mats L.
    [J]. BLOOD, 2007, 110 (11) : 163B - 164B
  • [8] Histamine and interleukin-2 in acute myelogenous leukemia
    Hellstrand, K
    Mellqvist, UH
    Wallhult, E
    Carneskog, J
    Kimby, E
    Celsing, F
    Brune, M
    [J]. LEUKEMIA & LYMPHOMA, 1997, 27 (5-6) : 429 - 438
  • [9] Interleukin-2 and histamine dihydrochloride in metastatic melanoma
    Agarwala, SS
    Hellstrand, K
    Naredi, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3558 - 3559
  • [10] Addressing the Incremental Benefit of Histamine Dihydrochloride When Added to Interleukin-2 in Treating Acute Myeloid Leukemia: A Bayesian Meta-Analysis
    Berry, Scott M.
    Broglio, Kristine R.
    Berry, Donald A.
    [J]. CANCER INVESTIGATION, 2011, 29 (04) : 293 - 299
12345